Fat Cavitation Market Size, Share & Trends Analysis Report By Application (Abdomen, Hips, Thighs), By Gender (Female, Male), By End-use (MedSpas, Cosmetic Surgery Centers, Hospitals), By Region, And Segment Forecasts, 2024 - 2030
Fat Cavitation Market Growth & Trends
The global fat cavitation market size is anticipated to reach USD 664.9 million by 2030 and is projected to grow at a CAGR of 10.6% from 2024 to 2030, based on a new report by Grand View research, Inc. The market growth is attributed to the changing aesthetic needs, increasing availability to finance invasive and non-invasive cosmetic surgeries, and growing collaboration between manufacturers and other service intermediaries.
The availability to finance cosmetic surgeries at distributed monthly cost propels patients to undergo cosmetic procedures such as fat cavitation in developed countries such as the U.S. and Germany. For instance, in April 2022, PatientFi and Allergan Aesthetics expanded their marketing agreement, allowing the former company to provide financing options to the latter’s product portfolio.
In addition, obesity rates across the world are expected to create opportunities for the global market. According to an article released by the World Obesity Federation in May 2022, nearly one billion people around the globe are likely to develop obesity by 2030. The prevalence of obesity is estimated to be nearly 1 in 5 for women and 1 in 7 for men.
Fat Cavitation Market Report Highlights
The global market size was estimated at USD 363.3 million in 2023 and is expected to reach 664.9 USD million in 2030
The global market is expected to grow at a CAGR of 10.6% from 2024 to 2030
Based on gender, the female segment led the market with the largest revenue share of 82.7% in 2023. It is due to high acceptability of cosmetic procedures in women than men
Based on application, the abdomen segment led the market with the largest revenue share of 27.84% in 2023. Genetics, lifestyle choices, and hormonal changes contribute to the development of stubborn fat deposits in this area
Based on end-use, the medspas segment led the market with the largest revenue share of 47.3% in 2023, due to the availability of advanced infrastructure, shorter waiting time, and the ability to serve patients on an outpatient preference
North America dominated the market with the revenue share of 43.08% in 2023. This growth can be attributed to the increasing acceptability of cosmetic procedures, growing product approvals from federal regulatory bodies, and availability of financing options
Please note The report will be delivered in 2-3 business days upon order notification.